SCHEMBL16840599

SCHEMBL16840599

c1ccc(-c2ccc(N(c3ccc(-c4ccccc4)cc3)c3ccc(-c4c5c(c(-c6ccc7c(c6)c6ccccc6n7-c6ccccc6)c6c4CCCC6)CCCC5)cc3)cc2)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 3/20 0.43
▸ L3MBTL1 Q9Y468 2/20 0.43
▸ ATM Q13315 1/20 0.43
▸ KMT2A Q03164 2/20 0.38
▸ SMN1; SMN2 Q16637 1/20 0.38
▸ TSPO P30536 1/20 0.37
▸ MYC P01106 1/20 0.36
▸ BCHE P06276 1/20 0.34
▸ ACHE P22303 1/20 0.34
▸ PTGER4 P35408 1/20 0.34
▸ HDAC4 P56524 1/20 0.33
▸ IL1R1 P14778 1/20 0.33
▸ MAPT P10636 2/20 0.32
▸ LMNA P02545 1/20 0.32
▸ CYP1A2 P05177 1/20 0.32
▸ CYP2C9 P11712 1/20 0.32
▸ CYP2C19 P33261 1/20 0.32
▸ TDP1 Q9NUW8 1/20 0.32
▸ ALDH1A1 P00352 2/20 0.32
▸ MEN1 O00255 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16840594 0.99 KDM4E (0.42) KDM4EL3MBTL1ATMKMT2ASMN1; SMN2
SCHEMBL16840636 0.99 KDM4E (0.42) KDM4EL3MBTL1ATMKMT2ASMN1; SMN2
SCHEMBL16840610 0.99 KDM4E (0.42) KDM4EL3MBTL1ATMKMT2ASMN1; SMN2
SCHEMBL16840612 0.96 KDM4E (0.42) KDM4EL3MBTL1ATMKMT2ASMN1; SMN2
SCHEMBL16840551 0.93 KDM4E (0.39) KDM4EL3MBTL1ATMKMT2ASMN1; SMN2
SCHEMBL16840557 0.93 KDM4E (0.41) KDM4EL3MBTL1ATMKMT2ASMN1; SMN2
SCHEMBL16840621 0.93 KDM4E (0.44) KDM4EL3MBTL1ATMKMT2ASMN1; SMN2
SCHEMBL16840622 0.93 KDM4E (0.44) KDM4EL3MBTL1ATMKMT2ASMN1; SMN2
SCHEMBL16840615 0.92 KDM4E (0.42) KDM4EL3MBTL1ATMKMT2ASMN1; SMN2
SCHEMBL16840660 0.91 KDM4E (0.45) KDM4EL3MBTL1ATMKMT2ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150179942-A1 MATERIAL FOR ORGANIC ELECTROLUMINESCENCE DEVICE AND ORGANIC ELECTROLUMINESCENCE DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2015-06-25 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150179942-A1 MATERIAL FOR ORGANIC ELECTROLUMINESCENCE DEVICE AND ORGANIC ELECTROLUMINESCENCE DEVICE INCLUDING THE SAME L1CAM, MCOLN2, LAS1L KDM4E 3719/4885L3MBTL1 33/4885ATM 1208/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback